Millennium Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Millennium Management’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.24M	Sell	107,912 -231,442	-68%	-$7.66M	﹤0.01%	3400
2025 Q4	$11.1M	Buy	339,354 +186,452	+122%	+$6.02M	﹤0.01%	2155
2025 Q3	$5.3M	Sell	152,902 -37,807	-20%	-$1.21M	﹤0.01%	3090
2025 Q2	$5.34M	Buy	190,709 +127,645	+202%	+$3.42M	﹤0.01%	2919
2025 Q1	$1.58M	Buy	63,064 +20,789	+49%	+$525K	﹤0.01%	3990
2024 Q4	$1.16M	Sell	42,275 -225,079	-84%	-$6.27M	﹤0.01%	4079
2024 Q3	$7.7M	Sell	267,354 -74,285	-22%	-$2.02M	﹤0.01%	2434
2024 Q2	$8.47M	Buy	341,639 +17,089	+5%	+$485K	﹤0.01%	2237
2024 Q1	$10.5M	Buy	324,550 +261,994	+419%	+$9.74M	﹤0.01%	2145
2023 Q4	$2.54M	Buy	62,556 +40,177	+180%	+$1.48M	﹤0.01%	3404
2023 Q3	$773K	Sell	22,379 -52,193	-70%	-$2.03M	﹤0.01%	4360
2023 Q2	$3.03M	Sell	74,572 -275,123	-79%	-$11.2M	﹤0.01%	3127
2023 Q1	$13.5M	Sell	349,695 -5,660	-2%	-$233K	0.01%	1679
2022 Q4	$15.8M	Buy	355,355 +194,226	+121%	+$8.17M	0.01%	1662
2022 Q3	$6.87M	Buy	161,129 +136,121	+544%	+$6.97M	﹤0.01%	2581
2022 Q2	$1.4M	Sell	25,008 -290,123	-92%	-$17.2M	﹤0.01%	4058
2022 Q1	$19.5M	Buy	315,131 +80,951	+35%	+$4.95M	0.01%	1422
2021 Q4	$12.9M	Buy	234,180 +23,535	+11%	+$1.23M	0.01%	1873
2021 Q3	$11.1M	Buy	210,645 +64,696	+44%	+$3.84M	0.01%	1926
2021 Q2	$10.1M	Sell	145,949 -55,918	-28%	-$4.26M	0.01%	1896
2021 Q1	$15.6M	Buy	201,867 +113,357	+128%	+$10.4M	0.01%	1325
2020 Q4	$8.76M	Buy	88,510 +74,623	+537%	+$9.13M	0.01%	1875
2020 Q3	$1.97K	Buy	13,887 +3,257	+31%	+$543K	﹤0.01%	2610
2020 Q2	$2.1M	Buy	10,630 +490	+5%	+$101K	﹤0.01%	2501
2020 Q1	$1.99M	Sell	10,140 -4,687	-32%	-$1.01M	﹤0.01%	2028
2019 Q4	$3.07M	Buy	+14,827	New	+$2.74M	﹤0.01%	2321
2019 Q3	–	Sell	-38,110	Closed	-$4.91M	–	4306
2019 Q2	$4.91M	Buy	38,110 +5,847	+18%	+$694K	0.01%	1799
2019 Q1	$3.8M	Sell	32,263 -40,275	-56%	-$4.06M	0.01%	1949
2018 Q4	$6.66M	Buy	72,538 +9,217	+15%	+$934K	0.01%	1383
2018 Q3	$7.12M	Buy	63,321 +29,822	+89%	+$3.15M	0.01%	1551
2018 Q2	$3.09M	Sell	33,499 -1,077	-3%	-$104K	﹤0.01%	2114
2018 Q1	$3.45M	Sell	34,576 -10,828	-24%	-$1.17M	﹤0.01%	2021
2017 Q4	$4.26M	Buy	+45,404	New	+$4.29M	0.01%	1816
2017 Q3	–	Sell	-41,458	Closed	-$3.17M	–	3634
2017 Q2	$3.17M	Buy	+41,458	New	+$3.49M	0.01%	1787
2015 Q3	–	Sell	-32,695	Closed	-$1.68M	–	3553
2015 Q2	$1.68M	Buy	+32,695	New	+$1.73M	﹤0.01%	2018

Other funds holding LKFT

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

DCM

DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management's LKFT Position: Q1 2026 in Review

Millennium Management reduced its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 68% in Q1 2026, selling an estimated $7.66M and leaving 107,912 shares worth $3.24M. The position accounts for ﹤0.01% of the portfolio, ranked #3400.

Millennium Management first reported a position in LKFT in Q2 2015 and has held it in 35 quarters since. The position peaked at $19.5M in Q1 2022. 90 funds tracked by Wall St. Rank hold LKFT as of Q1 2026.

Millennium Management held 107,912 shares of Lakefront Biotherapeutics American Depositary Shares worth $3.24M as of Q1 2026.
Millennium Management sold 231,442 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2026, an estimated $7.66M.
Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3400 holding.
Millennium Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2015 and has held it in 35 quarters since.
Millennium Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $19.5M in Q1 2022.
90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.